KYLO-0603, a novel liver-targeting, thyroid hormone receptor-beta agonist for the inhibition of MASH progression. Lu X, Wang S, Du Y, Xie B, et al. PLoS One 2025;20:e0331768.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lu X, Wang S, Du Y, Xie B, et al. KYLO-0603, a novel liver-targeting, thyroid hormone receptor-beta agonist for the inhibition of MASH progression. PLoS One 2025;20:e0331768.
PMID: 40953087